Innovation
3 patent families (2 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities; filing pace steady. Cited 60 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 9.9K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
19 investors on record; lead investors include Third Kind Venture Capital, Dynamk Capital, Red Cell Partners, New York State.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 63% |
| Private equity | 1 | 5% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 5 | 26% |
Recent activity
9 Jun 2026
Event
Long Island Tech & Innovation Summit fireside chat
5 May 2026
Event
Emerging Targets for Oncology & Beyond session
30 Apr 2026
Event
26th BioPharma Drug Discovery Nexus Conference